US Stock Insider Trading | SenesTech Discloses 3 Insider Transactions on February 19

2026-02-24 01:40:21

On February 19, 2026, SenesTech (SNES) disclosed three insider trading transactions. The shareholder holding more than 10%, GLENBROOK CAPITAL MANAGEMENT, purchased 40,800 shares on February 19, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 19, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 18, 2026	Buy	10,500	2.29	24,000
February 19, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 17, 2026	Buy	40,800	2.29	93,500
February 19, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 19, 2026	Buy	34,600	2.40	83,100
February 13, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 12, 2026	Buy	7,956	1.72	13,700
February 13, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 13, 2026	Buy	15,400	1.89	29,100
February 13, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 11, 2026	Buy	8,000	1.73	13,900
February 6, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 5, 2026	Buy	2,884	1.77	5,106.12
February 6, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 4, 2026	Buy	5,685	1.82	10,400
February 3, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	February 2, 2026	Buy	42,700	1.98	84,400
February 3, 2026	Shareholder >10%	GLENBROOK CAPITAL MANAGEMENT	January 30, 2026	Buy	5,399	1.87	10,100

[Company Information]

SenesTech, Inc. was incorporated in Nevada on July 27, 2004. The company has developed proprietary technology to manage animal pest populations through reproductive control. The company believes its innovation lies in non-lethal methods and targeted reproduction, which reduce environmental harm in a more humane way, providing a more effective and sustainable solution compared to traditional lethal pest control methods.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.